(Press-News.org) We are truly never alone, not even within our own bodies. Human beings play host to trillions of bacteria, fungi, viruses, and other microorganisms that make up the human microbiome. In recent years, the mix of these resident bacteria, and the presence of specific bacterial species, has been linked to conditions ranging from obesity to multiple sclerosis.
Now, going a step farther, researchers at Harvard Medical School and Joslin Diabetes Center have gone beyond microbial species. Analyzing the genetic makeup of bacteria in the human gut, the team has successfully linked groups of bacterial genes, or "genetic signatures," to multiple diseases.
The work brings scientists closer to developing tests that could predict disease risk or identify disease presence based on a sampling of the genetic makeup of a person's microbiome.
The findings, to be published May 18 in Nature Communications, link sets of bacterial genes to the presence of coronary artery disease, cirrhosis of the liver, inflammatory bowel disease, colon cancer, and type 2 diabetes. The analysis indicates that three of these conditions--coronary artery disease, inflammatory bowel disease, and liver cirrhosis--share many of the same bacterial genes. In other words, people whose guts harbor these bacterial genes seem more likely to have one or more of these three conditions.
The work represents a significant advance in the current understanding of the relationship between microbes residing in the human gut and specific diseases, the team said. If confirmed through further research, the results could inform the design of tools that could gauge a person's risk for a range of conditions based on analysis of a single fecal sample, they added.
"This opens a window for the development of tests using cross-disease, gene-based indicators of patient health," said first author Braden Tierney, a graduate student in the Biological and Biomedical Sciences program at HMS. "We've identified genetic markers that we think could eventually lead to tests, or just one test, to identify associations with a number of medical conditions."
The researchers caution that their study was not designed to elucidate exactly how and why these microbial genes may be linked to different diseases. Thus far, they said, it remains unclear whether these bacteria are involved in disease development or are mere bystanders in this process.
The goal of the study was to determine whether groups of genes could reliably indicate the presence of different diseases. These newly identified microbial genetic signatures, however, could be studied further to determine what role, if any, the organisms play in disease development.
"Our study underscores the value of data science to tease out complex interplay between microbes and humans," said study senior author Chirag Patel, associate professor of biomedical informatics in the Blavatnik Institute at HMS.
The researchers started out by collecting microbiome data from 13 groups of patients totaling more than 2,500 samples. Next, they analyzed the data to pinpoint linkages between seven diseases and millions of microbial species, microbial metabolic pathways, and microbial genes. By trying out a variety of modeling approaches--computing a total of 67 million different statistical models--they were able to observe what microbiome features consistently emerged as the strongest disease-associated candidates.
Of all the various microbial characteristics--species, pathways, and genes--microbial genes had the greatest predictive power. In other words, the researchers said, groups of bacterial genes, or genetic signatures, rather than merely the presence of certain bacterial families, were linked most closely to the presence of a given condition.
Some of the main observations included:
Clusters of bacterial genes, or genetic signatures, rather than individual bacterial genes, appear implicated in various types of human disease.
Coronary artery disease, inflammatory bowel disease, and liver cirrhosis have similar gut microbiome genetic signatures.
Type 2 diabetes, by contrast, has a microbiome signature unlike any other phenotype tested.
The analysis did not find a consistent link between the presence of the bacterial species Solobacterium moorei and colon cancer--an association previously reported in numerous studies. However, the researchers did identify particular genes from a S. moorei subspecies associated with colorectal cancer. This finding indicates that gene-level analysis can yield biomarkers of disease with greater precision and more specificity compared with current approaches. Patel said this result underscores the notion that it is not merely the presence of a given bacterial family that may portend risk, but rather the strains and gene signatures of the microbes that matter. The ability to identify interconnections with such precision will be critical for designing tests that can measure risk reliably, he added. Thus, in this specific example, a test intended to measure colon-cancer risk by merely detecting the presence of S. moorei in the gut may not be as reliable as a more refined test that measures bacterial genes to detect the presence of specific strains of S. moorei that are associated with colon cancer.
Two conditions--ear inflammation and benign soft-tissue tumors called adenomas--showed weak associations with the gut microbiome, suggesting that microorganisms residing in the human gut are not likely to play a role in the development of these conditions, nor are they likely to be reliable indicators that these conditions are present.
In a previous study, the HMS team used massive amounts of publicly available DNA-sequencing data from human oral and gut microbiomes to estimate the size of the universe of microbial genes in the human body. The analysis revealed that there may be more genes in the collective human microbiome than stars in the observable universe.
Given the sheer number of microbial genes that reside within the human body, the new findings represent a major step forward in understanding the complexity of the interplay between human diseases and the human microbiome, the researchers said.
"The ultimate goal of computational science is to generate hypotheses from a huge swath of data," said Tierney. "Our work shows that this can be done and opens up so many new avenues for research and inquiry that we are only limited by the time, people, and resources needed to run those tests."
INFORMATION:
Co-investigators included Yingxuan Tan and Aleksander Kostic.
This research was supported by the National Institutes of Health (T32 DK110919), National Science Foundation (1636870), National Institute of Allergy and Infectious Diseases (R01AI127250), American Diabetes Association Pathway to Stop Diabetes Initiator Award (1-17-INI-13), and Smith Family Awards Program for Excellence in Biomedical Research.
The DOI for this paper will be 10.1038/s41467-021-23029-8
Optimistic predictions expect reliable autonomous vehicles to be commercially available by 2030, at a time when mobility is undergoing a profound shift away from traditional modes of transportation and towards door-to-door services. Previous analysis suggested that public transport will lose market share to autonomous vehicles, but the environmental impact of changing transport use has hardly been considered. New research shows that the convenience of autonomous vehicles would likely come at an environmental cost.
A recent paper by researchers from the University of Wisconsin-Madison addresses the use-phase implications of autonomous vehicles using a stated preference ...
Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for aortic valve surgery, less is known about TAVI in patients who are at low risk for complications or death from surgery. At EuroPCR 2021, Dr J Forrest will present the complete 2-year follow-up from the Evolut low risk trial.
The Evolut Low Risk trial is a randomized noninferiority trial in which TAVI with a self-expanding supraannular bioprosthesis ...
Previous clinical trials suggested that ultra-thin strut biodegradable polymer sirolimus-eluting stent (BP-SES) may be associated with lower target lesion failure (TLF) when compared to durable polymer everolimus-eluting stents (DP-EES). However, the possible underlying mechanisms remain unclear. Therefore, the all-comers CASTLE study was designed to assess the role of imaging-guided percutaneous cardiac intervention (PCI) in the clinical outcomes difference between BP-SES vs DP-EES.
BP-SES has ultra-thin struts (60μm) and a biodegradable polymer that may provide potential advantages such as reduced vessel inflammation and thrombogenicity. ...
The European Bifurcation Club Left Main (EBC MAIN) trial addressed the issue of provisional single stent versus upfront double stenting in 467 patients with true bifurcation distal left main disease.
So far, only one other randomized trial, DKCRUSH-V (n=482), has addressed the same research question, showing better outcomes with an upfront two-stent strategy, more specifically the double-kissing crush (DK CRUSH) technique.
In terms of methodology, two aspects need to be considered for the correct interpretation of the EBC MAIN trial results. First, both LAD and CX ostia were affected by significant disease on angiography ...
Results of the interim analyses performed after 12 months in the first 111 patients enrolled in phase II Cool AMI trial evaluating safety and effectiveness of systemic therapeutic hypothermia as an adjunctive therapy in anterior STEMI undergoing PCI as compared to PCI only. Analyses showed significant differences among treatment groups, including longer randomization-to-balloon time and total ischemic time in treatment arm, justifying premature trial discontinuation.
Therapeutic mild systemic hypothermia, when achieved before reperfusion of the infarct related vessel, has shown to limit infarct size in experimental animal models. Despite ...
The ISCHEMIA trial found no significant difference between an invasive vs. a conservative strategy in patients with chronic coronary syndromes and moderate to severe ischemia at a mean of 3.2 years. However, the cumulative difference in the estimates of cardiac death between the invasive and conservative strategies tended to increase numerically over time (e.g., 0.3% in favor of the invasive strategy at 2 years and 1.3% at 5 years). Because the ISCHEMIA trial was not powered for cardiac mortality and did not focus on long-term follow-up, the rationale for a meta-analysis emerged.
At EuroPCR 2021, Navarese and colleagues present the results of a new meta-analysis of revascularization plus medical therapy versus medical therapy alone. A total of 19,806 patients with chronic coronary syndromes ...
Imagine an entire twenty storey concrete building which can store energy like a giant battery. Thanks to unique research from Chalmers University of Technology, Sweden, such a vision could someday be a reality. Researchers from the Department of Architecture and Civil Engineering recently published an article outlining a new concept for rechargeable batteries - made of cement.
The ever-growing need for sustainable building materials poses great challenges for researchers. Doctor Emma Zhang, formerly of Chalmers University of Technology, Sweden, joined Professor Luping Tang's research group several years ago to search for the building materials of the future. Together they have now succeeded in developing a world-first ...
Researchers have developed a tool to help governments and other organizations with limited budgets spend money on building repairs more wisely.
The new tool uses artificial intelligence (AI) and text mining techniques to analyze written inspection reports and determine which work is most urgently needed.
"Those assessments are now largely subjective, the opinions of people based on experience and training," said Kareem Mostafa, an engineering PhD student at the University of Waterloo who led the project. "We're using actual data on buildings to make spending decisions more objective."
Researchers looked at inspection reports on the roofs of 400 schools managed by the Toronto District School Board. A computer ...
MUSC Hollings Cancer Center lung cancer researcher Gerard Silvestri, M.D., found that a lack of insurance leads to worse cancer survival than for those with Medicare, in a paper published in the May issue of Health Affairs. This work, a joint effort between Silvestri and researchers at the American Cancer Society, highlights the current dire barrier in medical care: Many people cannot take advantage of the newer potentially lifesaving treatments due to the high costs.
Silvestri said the research began last year, inspired by the hotly debated topic of expanding Medicare ...
The Korea Institute of Machinery and Materials (KIMM) under the Ministry of Science and ICT developed a roll-based damage-free transfer technique that allows two-dimensional (2D) nanomaterials to be transferred into wafer scale without damage. The proposed technique has a variety of applications from transparent displays and semiconductors to displays for self-driving cars, and is expected to accelerate the commercialization of 2D nanomaterial-based high-performance devices.
Dr. Kwang-Seop Kim, principal researcher of the Department of Nano-Mechanics at KIMM, succeeded in developing a technique of transferring 2D nanomaterials, as thin as 1/50,000 of a strand of hair, to a substrate of at least 4 inches (approx. 10 cm) without damage.
The roll-based transfer is a process in ...
